Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$207.01 - $276.09 $2.06 Million - $2.75 Million
-9,962 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $944,626 - $1.12 Million
-3,695 Reduced 27.06%
9,962 $2.71 Million
Q2 2020

Aug 10, 2020

BUY
$225.48 - $295.8 $3.08 Million - $4.04 Million
13,657 New
13,657 $3.97 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $415,321 - $515,196
-2,079 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $2.21 Million - $2.96 Million
-13,241 Reduced 86.43%
2,079 $455,000
Q3 2019

Nov 12, 2019

SELL
$166.23 - $187.09 $360,386 - $405,611
-2,168 Reduced 12.4%
15,320 $2.6 Million
Q2 2019

Nov 12, 2019

BUY
$164.61 - $190.37 $2.88 Million - $3.33 Million
17,488 New
17,488 $3.21 Million
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $3.89 Million - $4.93 Million
-25,630 Closed
0 $0
Q3 2018

Feb 13, 2019

BUY
$167.73 - $192.74 $2.55 Million - $2.93 Million
15,176 Added 145.17%
25,630 $4.94 Million
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $612,169 - $714,001
4,201 Added 67.18%
10,454 $1.78 Million
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $484,816 - $566,461
3,198 Added 104.68%
6,253 $992,000
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $419,390 - $475,205
3,055
3,055 $458,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.